Tonix Pharmaceuticals Holding Corp.
TNXP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$130,036 | -$116,658 | -$110,218 | -$92,287 |
| Dep. & Amort. | $3,421 | $4,291 | $1,253 | $50 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4,778 | $9,275 | $10,914 | $7,899 |
| Change in WC | $5,775 | -$35 | -$2 | $5,781 |
| Other Non-Cash | $55,137 | $1,124 | $0 | $3,000 |
| Operating Cash Flow | -$60,925 | -$102,003 | -$98,053 | -$75,557 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$120 | -$7,895 | -$48,147 | -$35,307 |
| Net Acquisitions | $0 | -$22,174 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $999 | $0 | $0 |
| Investing Cash Flow | -$120 | -$29,070 | -$48,147 | -$35,307 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,350 | $8,942 | $0 | $0 |
| Stock Issued | $140,195 | $18,939 | $94,463 | $212,389 |
| Stock Repurch. | $0 | -$13,965 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,973 | $22,601 | -$6,619 | $98 |
| Financing Cash Flow | $134,872 | $36,517 | $87,844 | $212,487 |
| Forex Effect | $4 | -$65 | -$74 | -$31 |
| Net Chg. in Cash | $73,831 | -$94,621 | -$58,430 | $101,592 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $25,849 | $120,470 | $178,900 | $77,308 |
| End Cash | $99,680 | $25,849 | $120,470 | $178,900 |
| Free Cash Flow | -$61,045 | -$109,898 | -$146,200 | -$110,864 |